• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 17
  3. 18
  4. 19
  5. 20
  6. 21
  7. …
  • Medicago vaccine approved

    Canada // 04 March, 2022

    Effective against Omicron variant...

    COVID-19

  • Oral antiviral Molnupiravir conditionally recommended by WHO to treat COVID-19

    03 March, 2022

    The conditional approval is for use in adults at high risk of hospitalisation...

    COVID-19

  • New plan to manage COVID-19 announced

    United States // 02 March, 2022

    Plan focuses on 4 key goals…

    COVID-19

  • Vaccine Update – Vaccinations for 5 to 11 years have begun

    Japan // 02 March, 2022

    Vaccinations for children aged 5 to 11 years with underlying conditions has begun...

    COVID-19

  • COVID-19 in felines

    Belgium // Brazil // Estonia // France // Germany // Hong Kong (China SAR) // India // South Korea // Spain // Switzerland // United Kingdom // United States // Uruguay // 25 February, 2022

    COVID-19 infections in felines in various settings...

    COVID-19

  • Vaccine Pass initiative launched

    Hong Kong (China SAR) // 24 February, 2022

    Officials have launched the Vaccine Pass with the aim to...

    COVID-19

  • Treatment guidelines issued for children including infants

    Vietnam // 24 February, 2022

    Guidelines treatment for children updated.

    COVID-19

  • Record number of new COVID-19 cases

    Singapore // 23 February, 2022

    Over 26,000 cases reported...

    COVID-19

  • WHO COVID-19 Weekly Reports, February 2022

    22 February, 2022

    Summary of WHO weekly reports...

    COVID-19

  • WHO statement on Omicron sublineage BA.2

    22 February, 2022

    WHO's Technical Advisory Group met to discuss Omicron...

    COVID-19

  • Changes to COVID-19 vaccination programme

    South Africa // 22 February, 2022

    Booster shot eligibility...

    COVID-19

  • Vaccine Update - JCVI advises additional booster dose in spring, roll out awaited

    United Kingdom // 21 February, 2022

    Additional booster dose for the vulnerable...

    COVID-19

  • WHO updates EUL status of COVID-19 vaccines

    20 February, 2022

    WHO has published an update to the EUL status of COVID-19 vaccines...

    COVID-19

  • Vaccine update - Booster vaccination for children

    Cambodia // 18 February, 2022

    The vaccination campaign in Cambodia is one of the most progressed in Asia...

    COVID-19

  • Novavax approved for adults

    Canada // 17 February, 2022

    Five vaccines now available in the country…

    COVID-19

  • Vaccination during pregnancy protects infants

    United States // 16 February, 2022

    Up to 61% protection against hospitalisation…

    COVID-19

  • Vaccine Update – Vaccinations for children aged 5 to 11 years underway

    Malaysia // 16 February, 2022

    Vaccinations for children aged 5 to 11 years began on 3 February...

    COVID-19

  • Vaccine Update – 600,000 doses of vaccine delivered

    Hong Kong (China SAR) // 14 February, 2022

    Authorities have announced that the eligible age for the Sinovac vaccine will be lowered to three years old...

    COVID-19

  • COVID-19 vaccination status "up-to-date" rather than "fully vaccinated"

    Australia // 12 February, 2022

    Authorities now use the term "up-to-date" for public health management....

    COVID-19

  • Oral antiviral Paxlovid approved to treat COVID-19

    China // 12 February, 2022

    The conditional approval is for use in adults who are at high risk of progressing to severe disease....

    COVID-19

  1. …
  2. 17
  3. 18
  4. 19
  5. 20
  6. 21
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS